Indraprastha Medical Corporation Share Price

Indrapr.Medical

CMP as on 19-Oct-21 15:44

₹ 77.75
-1.55 -1.95%

Open

₹ 80.00

Turnover (lac)

₹ 143

Prev. Close

₹ 79.30

Day's Vol (shares)

₹ 1,83,536

Day's Range (₹)

₹ 77.50
₹ 80.45

CMP as on19-Oct-21 15:37

₹ 78.00
-1.35 -1.7%

Open

₹ 80.35

Turnover (lac)

₹ 231

Prev. Close

₹ 79.35

Day's Vol (shares)

₹ 43,237

Day's Range

₹ 77.40
₹ 80.35

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 31-Jul-2021 - -
INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Monday, 9th August, 2021, to consider and approve, the unaudited financial results for the quarter ended 30th June, 2021. This is for your information and record. This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 9th August, 2021 (i.e. today), inter-alia, considered and approved the following items: 1. Considered and approved the Un-audited Financial Results for the quarter ended 30th June, 2021, along with the Limited Review Report of the statutory auditor. 2. Approved the re-appointment of Mr. P. Shivakumar (DIN : 08570283) as Managing Director, for a period of 3 years effective from 5th November, 2021 to 4th November, 2024, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. 3. Approved convening the thirty-third Annual General Meeting (AGM) of the Company, on Friday, 24th September, 2021, through video conferencing and other audio visual means. 4. The Register of Members and Share Transfer Books of the Company shall remain closed from Saturday, 18th September, 2021 to Friday, 24th September, 2021 (both days inclusive) for the purpose of the AGM. This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 9th August, 2021 (i.e. today), inter-alia, considered and approved the following items: 1. Approved the re-appointment of Mr. P. Shivakumar (DIN : 08570283) as Managing Director, for a period of 3 years effective from 5th November, 2021 to 4th November, 2024, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company and such other approvals as may be necessary. 2. Approved convening the thirty-third Annual General Meeting (AGM) of the Company, on Friday, 24th September, 2021, through video conferencing and other audio visual means. 3. The Register of Members and Share Transfer Books of the Company shall remain closed from Saturday, 18th September, 2021 to Friday, 24th September, 2021 (both days inclusive) for the purpose of the AGM (As per BSE Announcement Dated on 9/8/2021) Indraprastha Medical Corporation Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 18, 2021 to September 24, 2021 (both days inclusive) for the purpose of 33rd Annual General Meeting (AGM) of the Company to be held on September 24, 2021. (As Per BSE Announcement dated on 10.08.2021)
Board Meeting - 01-Jun-2021 - -
INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/06/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Wednesday, 9th June, 2021, inter alia to consider and approve, the audited financial results for the quarter/ year ended 31st March, 2021. This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 9th June, 2021 (i.e. today), inter-alia, considered and approved the following items: 1. Considered and approved the Audited Financial Results for the quarter and financial year ended March 31, 2021, along with the audit report of the statutory auditor. 2. Noted the resignation of Ms. Madhumita Ganguli (DIN : 00676830) as Non-Executive Non-Independent Director from the Board of Directors of the Company. 3. Appointed Ms. Madhumita Ganguli (DIN : 00676830) as Independent Director of the Company, for a period of 5 consecutive years effective from 9th June, 2021 to 8th June, 2026, subject to the approval of the shareholders of the Company. Further, we wish to inform you that due to the impact of COVID-19 and uncertainty of growth in business, dividend on shares for the year 2020-21, has not been recommended by the Board. (As per BSE Announcement Dated on 09/06/2021)
Board Meeting - 07-Apr-2021 - -
This is to inform you that the Board of Directors of the Company at its meeting held on 7th April, 2021, have:- 1. Appointed Mr. Udit Prakash Rai (DIN: 07573658) as an Additional Director (Nominee Director of Govt. of NCT of Delhi) of the Board of Directors of the Company w.e.f. 7th April, 2021. As an Additional Director, he holds office of Director only up to the next Annual General Meeting (AGM) , and shall seek the approval of the shareholders at AGM for his appointment as a Director of the Company ; and 2. Appointed Mr. Vikram Bhat (DIN: 09076418) as an Additional Director (Nominee Director of Govt. of NCT of Delhi) of the Board of Directors of the Company w.e.f. 7th April, 2021. As an Additional Director, he holds office of Director only up to the next Annual General Meeting (AGM), and shall seek the approval of the shareholders at AGM for his appointment as a Director of the Company. A brief resume of the Directors appointed is attached.
Board Meeting - 29-Jan-2021 - -
INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Monday, 8th February, 2021, inter-alia to consider and approve, the unaudited financial results for the quarter and nine months ended 31st December, 2020 The Board of Directors of the Company at its meeting held on 8th February, 2021, have:- 1. Appointed Mr. Jasmine Shah (DIN: 08621290) as an Additional Director & Chairman 2. Appointed Prof. (Dr.) Mahesh Verma (DIN: 0008997324) as an Additional Director. 3. Appointed Mr. Salil Singhal (DIN: 00006629) as Independent Director of the Company, for a period of 5 consecutive years effective from 8th February, 2021 to 7th February, 2026, 4. Re-appointed Mr. Vinayak Chatterjee (DIN : 00008933) as Independent Director of the Company, for a period of 5 consecutive years effective from 1st April, 2021 to 31st March, 2026, 5. Noted the withdrawal of nomination of Ms. Vineeta Rai (DIN: 07013113) as a Nominee Director of Govt. of NCT of Delhi on the Board of Directors of the Company; and 6. Appointed Ms. Vineeta Rai (DIN: 07013113) as Independent Director of the Company, for a period of 5 consecutive years effective from 8th February, 2021 to 7th February, 2026. (As Per BSE Announcement dated on 08.02.2021)
Board Meeting - 04-Nov-2020 - -
INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday, 10th November, 2020, inter-alia to consider and approve, the unaudited financial results for the quarter and half year ended 30th September, 2020. This is for your information and record. The Board of Directors of the Company, at their meeting held on 10th November, 2020, have, inter alia, approved the Unaudited Financial Results for the quarter and half year ended 30th September, 2020. We are enclosing herewith a copy of the Unaudited Financial Results for the quarter and half year ended 30th September, 2020, along with a copy of the Limited Review Report by the Auditors. The Board meeting started at 12 noon and ended at 03.15 p.m. This is for your information and record. (As Per BSE Announcement dated on 10.11.2020)
Open ZERO Brokerage Demat Account